Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery
Summary
CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine ('Insilico', 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotec...
Description
CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine ('Insilico', 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotec...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source